Waters Corporation logo
Waters Corporation (WAT)
Compare

Waters Corporation (WAT) Return on Assets (ROA): 1.83%

Is Waters Corporation’s return on assets (ROA) high or low?

Waters Corporation's return on assets (ROA) of 1.83% is 89% below its 5-year average of 17.15%, near the low end of its 5-year range (1.83%–22.39%).

As of Thursday, June 11, 2026. 86.28% below its 12-month average of 13.34%.

WAT Return on Assets (ROA) Chart

WAT Return on Assets (ROA)
12.66%-9.64% 1Y
Zoom

WAT Average Return on Assets (ROA) Chart

WAT Current vs Average Return on Assets (ROA) Chart

WAT Return on Assets (ROA) Metrics

RETURN ON ASSETS (ROA)

1.83%

RETURN ON ASSETS (ROA) AVG TTM

13.34%

RETURN ON ASSETS (ROA) AVG 3Y

15.53%

RETURN ON ASSETS (ROA) AVG 5Y

17.15%

RETURN ON ASSETS (ROA) AVG 10Y

14.96%

RETURN ON ASSETS (ROA) AVG 15Y

14.70%

RETURN ON ASSETS (ROA) AVG 20Y

14.96%

CURRENT VS TTM AVG

-86.28%

CURRENT VS 3Y AVG

-88.22%

CURRENT VS 5Y AVG

-89.33%

CURRENT VS 10Y AVG

-87.77%

CURRENT VS 15Y AVG

-87.55%

CURRENT VS 20Y AVG

-87.76%

WAT Competitors' Return on Assets (ROA)

NAMEMARKET CAPRETURN ON ASSETS (ROA)TTM3Y5Y
Waters Corporation (WAT)$23.21B1.83%13.34%15.53%17.15%
Mettler-Toledo International Inc. (MTD)$22.82B23.85%25.02%24.63%23.85%
BioNTech SE (BNTX)$22.39B-6.03%-3.96%9.16%17.06%
Veeva Systems Inc. (VEEV)$26.31B10.31%9.93%9.72%10.43%
Moderna, Inc. (MRNA)$18.71B-27.80%-24.02%-10.32%-0.33%
DexCom, Inc. (DXCM)$28.92B14.03%11.04%9.26%8.83%
Biogen Inc. (BIIB)$28.94B4.65%5.11%6.74%8.29%
Hologic, Inc. (HOLX)$16.97B5.92%7.45%8.56%11.79%
IQVIA Holdings Inc. (IQV)$30.08B4.67%4.82%4.76%4.01%
Medline Inc. (MDLN)$30.90B2.47%3.17%1.75%1.75%

Asset Efficiency

ROA

1.8%

ROE

2.9%

Waters Corporation Return on Assets (ROA) Formula & Definition

ROA = Net Income / Total Assets

Return on assets measures how efficiently a company generates profit from its total assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Waters Corporation Return on Assets (ROA) FAQ

What is the return on assets (ROA) for Waters Corporation (WAT)?
The return on assets (ROA) for WAT stock is 1.83%.
Is Waters Corporation's return on assets (ROA) high or low?
Waters Corporation's return on assets (ROA) of 1.83% is 89% below its 5-year average of 17.15%, near the low end of its 5-year range (1.83%–22.39%).
What is the TTM average return on assets (ROA) for Waters Corporation (WAT)?
The TTM average return on assets (ROA) for WAT stock is 13.34%.
What is the 3Y average return on assets (ROA) for Waters Corporation (WAT)?
The 3Y average return on assets (ROA) for WAT stock is 15.53%.
What is the 5Y average return on assets (ROA) for Waters Corporation (WAT)?
The 5Y average return on assets (ROA) for WAT stock is 17.15%.
What is the 10Y average return on assets (ROA) for Waters Corporation (WAT)?
The 10Y average return on assets (ROA) for WAT stock is 14.96%.
What is the 15Y average return on assets (ROA) for Waters Corporation (WAT)?
The 15Y average return on assets (ROA) for WAT stock is 14.70%.
What is the 20Y average return on assets (ROA) for Waters Corporation (WAT)?
The 20Y average return on assets (ROA) for WAT stock is 14.96%.

Waters Corporation Return on Assets (ROA) History

DATERETURN ON ASSETS (ROA)
2025-12-3112.66%
2024-12-3114.01%
2023-12-3113.88%
2022-12-3121.57%
2021-12-3122.39%
2020-12-3118.37%
2019-12-3123.16%
2018-12-3115.93%
2017-12-310.38%
2016-12-3111.19%
2015-12-3111.01%
2014-12-3111.13%
2013-12-3112.59%
2012-12-3114.57%
2011-12-3115.90%
2010-12-3116.40%
2009-12-3116.95%
2008-12-3119.87%
2007-12-3114.25%
2006-12-3113.74%
2005-12-3114.13%
2004-12-3115.34%
2003-12-3115.11%
2002-12-3114.61%
2001-12-3112.91%
2000-12-3120.99%
1999-12-3120.93%
1998-12-3112.88%
1997-12-31-1.50%
1996-12-31-0.66%

About Waters Corporation

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

Milford, MA
7,600 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Udit Batra